TORRENT PHARMACEUTICALS L vs Zenith Health Care Ltd

A side-by-side comparison of TORRENT PHARMACEUTICALS L (TORNTPHARM) and Zenith Health Care Ltd (ZENITHHE) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, TORRENT PHARMACEUTICALS L leads TORNTPHARM vs ZENITHHE on 11 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation31
  • Profitability40
  • Growth10
  • Size & financial health31
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

TORNTPHARM takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

75.99
P/E ratio
321.00
18.67
P/B ratio
2.21
0.76%
Dividend yield
0.00%
₹63.92
EPS
₹0.01

Profitability

TORNTPHARM takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

27.40%
Return on equity
0.13%
15.00%
Return on capital
3.12%
33.00%
EBITDA margin
0.79%
15.29%
Net margin
0.62%

Growth

TORNTPHARM takes 1/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

13.27%
Revenue CAGR (3Y)
-6.02%
19.75%
Profit CAGR (3Y) even

Size & financial health

TORNTPHARM takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.64L Cr
Market cap
₹17 Cr
₹13,980 Cr
Revenue
₹11 Cr
₹2,138 Cr
Net profit
₹0 Cr
1.69
Debt / equity
0.00
TORRENT PHARMACEUTICALS L
  • + ["Company is expected to give good quarter", "Company has a good return on equity (ROE) track record: 3 Years ROE 26.2%", "Company has been maintaining a healthy dividend payout of 57.8%"]
  • ["Stock is trading at 20.4 times its book value", "Promoter holding has decreased over last quarter: -7.53%", "The company has delivered a poor sales growth of 11.8% over past five years.", "Company might be capitalizing the interest cost"]
Zenith Health Care Ltd
  • + ["Company is almost debt free."]
  • ["Though the company is reporting repeated profits, it is not paying out dividend", "The company has delivered a poor sales growth of -5.20% over past five years.", "Promoter holding is low: 28.7%", "Company has a low return on equity of 0.77% over last 3 years.", "Working capital days have increased from 84.2 days to 122 days"]
TORRENT PHARMACEUTICALS L full analysis Zenith Health Care Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

TORNTPHARM vs ZENITHHE: Share Price, Valuation & Which to Buy | DocStoX